Baseline correction examples [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2016-02-07 04:05 (3393 d 18:46 ago) – Posting: # 15939
Views: 23,736

Hi Lucas and Helmut

»No method is “perfect”. What about performing such a study in postmenopausal women?

Yes! This is my doubt! Why worry with high fluctuations in the endogenous baseline due to cir­ca­dian rhythms to some hormones, as Estradiol, for example, if is possible performing the study with healthy, physiologically or surgically postmenopausal females, single-dose and blood samples colected no more than 96 hours (http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM238055)? :confused:

The levels should be low and stable, because the circulating estradiol after menopause is approximately 10-20 pg / ml and the greater part of which is derived from peripheral conversion of estrone.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
45 visitors (0 registered, 45 guests [including 28 identified bots]).
Forum time: 23:51 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5